The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
43
40mg by mouth twice daily
Clinical Trials Office, Aston Building, UT Southwestern
Dallas, Texas, United States
Total Nasal Symptom Scores
(1=none, 7=unbearably severe) difference in nasal symptom scores for the average of the last two weeks of each treatment arm
Time frame: Last two weeks of each treatment arm
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.